Astella purchases Maxygen equity interest in Perseid Therapeutics
Under the terms of the companies’ 2009 joint venture arrangement, Maxygen transferred all of its protein pharmaceutical programs and related assets and research and development personnel to Perseid
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.